|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 341 for Snrpb

<< First    < Previous  |  Next >    Last >>
0.035s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Cdkn2a Kras
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S1/Sv * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Pten/Pten<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S1/Sv * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ednrb/Ednrb Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ednrb/Ednrb Tg(Dct-lacZ)#Ove/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Mc1r/Mc1r Tg(Dct-lacZ)#Ove/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pikfyve/Pikfyve Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: C57BL/6 * C57BL/6J
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129 * 129S4/SvJae * 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S4/SvJaeSor * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: B6.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Publication
28869973 | J:252840
First Author: Chen S
Year: 2017
Journal: Nature
Title: Palmitoylation-dependent activation of MC1R prevents melanomagenesis.
Volume: 549
Issue: 7672
Pages: 399-403
•
•
•
•
•
Publication
20550935 | J:167944
First Author: Levy C
Year: 2010
Journal: Cell
Title: Lineage-specific transcriptional regulation of DICER by MITF in melanocytes.
Volume: 141
Issue: 6
Pages: 994-1005
•
•
•
•
•
Publication
32193336 | J:289992
First Author: Sharma S
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Volume: 117
Issue: 14
Pages: 8001-8012
•
•
•
•
•
Publication
24019069 | J:206100
First Author: Lee EK
Year: 2013
Journal: Mol Cell Biol
Title: The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.
Volume: 33
Issue: 22
Pages: 4422-33
•
•
•
•
•
Publication
25705882 | J:221902
First Author: Kwong LN
Year: 2015
Journal: J Clin Invest
Title: Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
Volume: 125
Issue: 4
Pages: 1459-70
•
•
•
•
•
Publication
26206884 | J:329611
First Author: Fufa TD
Year: 2015
Journal: Hum Mol Genet
Title: Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes.
Volume: 24
Issue: 19
Pages: 5433-50
•
•
•
•
•
Publication
20048081 | J:155731
First Author: Held MA
Year: 2010
Journal: Cancer Res
Title: Characterization of melanoma cells capable of propagating tumors from a single cell.
Volume: 70
Issue: 1
Pages: 388-97
•
•
•
•
•
Publication
30355677 | J:271155
First Author: Hill KS
Year: 2019
Journal: Mol Cancer Res
Title: PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.
Volume: 17
Issue: 2
Pages: 583-593
•
•
•
•
•
Publication
32238882 | J:335346
First Author: Uka R
Year: 2020
Journal: Oncogene
Title: Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.
Volume: 39
Issue: 20
Pages: 4132-4154
•
•
•
•
•
Publication
22698401 | J:189285
First Author: Liu W
Year: 2012
Journal: Cancer Cell
Title: LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.
Volume: 21
Issue: 6
Pages: 751-64
•
•
•
•
•
Publication
28368416 | J:247693
First Author: Schaefer SM
Year: 2017
Journal: Oncogene
Title: Sox2 is dispensable for primary melanoma and metastasis formation.
Volume: 36
Issue: 31
Pages: 4516-4524
•
•
•
•
•
Publication
25609585 | J:219707
 
First Author: Zingg D
Year: 2015
Journal: Nat Commun
Title: The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.
Volume: 6
Pages: 6051
•
•
•
•
•
Publication
26450788 | J:231490
First Author: Rai K
Year: 2015
Journal: Cancer Discov
Title: Dual Roles of RNF2 in Melanoma Progression.
Volume: 5
Issue: 12
Pages: 1314-27
•
•
•
•
•
Strain
MGI:6792067 | STOCK Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor<tm1(GNAQ*)Cvrk>/Gt(ROSA)26Sor<tm1Sor>/Cvrk
Attribute String: mutant stock, targeted mutation, transgenic
•
•
•
•
•
Publication
23935512 | J:213046
First Author: Harris ML
Year: 2013
Journal: PLoS Genet
Title: A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors.
Volume: 9
Issue: 7
Pages: e1003644
•
•
•
•
•
Publication
26113083 | J:225597
First Author: Huang JL
Year: 2015
Journal: Cancer Res
Title: Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.
Volume: 75
Issue: 16
Pages: 3384-97
•
•
•
•
•
Publication
25584893 | J:218894
First Author: Damsky W
Year: 2015
Journal: Cancer Cell
Title: mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Volume: 27
Issue: 1
Pages: 41-56
•
•
•
•
•
Publication
28192409 | J:243383
First Author: Tonks ID
Year: 2017
Journal: Oncogene
Title: Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.
Volume: 36
Issue: 26
Pages: 3789-3795
•
•
•
•
•
Publication
29438700 | J:257785
First Author: Yu Y
Year: 2018
Journal: Cancer Cell
Title: Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Volume: 33
Issue: 2
Pages: 322-336.e8
•
•
•
•
•
Strain
MGI:4948437 | B6.Cg-Tg(Tyr-cre/ERT2)13Bos Braf<tm1Mmcm> Pten<tm1Hwu>/BosJ
Attribute String: transgenic, targeted mutation, mutant strain, congenic
•
•
•
•
•
Publication
34689087 | J:312866
 
First Author: Le HH
Year: 2021
Journal: EBioMedicine
Title: Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Volume: 73
Pages: 103646
•
•
•
•
•
Publication
28376192 | J:245620
 
First Author: Bonet C
Year: 2017
Journal: J Natl Cancer Inst
Title: Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Volume: 109
Issue: 8
•
•
•
•
•
Publication
31449725 | J:309201
First Author: Zhai Y
Year: 2020
Journal: Pigment Cell Melanoma Res
Title: Differences in tumor initiation and progression of melanoma in the BrafCA ;Tyr-CreERT2;Ptenf/f model between male and female mice.
Volume: 33
Issue: 1
Pages: 119-121
•
•
•
•
•
Publication
30209062 | J:286512
First Author: Zhao F
Year: 2018
Journal: Cancer Immunol Res
Title: Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma.
Volume: 6
Issue: 12
Pages: 1459-1471
•
•
•
•
•
Publication
34597611 | J:333928
First Author: Chhabra G
Year: 2022
Journal: J Invest Dermatol
Title: Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in Braf(V600E)/Pten(NULL) Mice.
Volume: 142
Issue: 4
Pages: 1145-1157.e7
•
•
•
•
•
Publication
32620791 | J:293364
First Author: Ishak Gabra MB
Year: 2020
Journal: Nat Commun
Title: Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth.
Volume: 11
Issue: 1
Pages: 3326
•
•
•
•
•
Publication
29179997 | J:253811
 
First Author: Rodríguez CI
Year: 2018
Journal: Cancer Lett
Title: Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression.
Volume: 414
Pages: 268-277
•
•
•
•
•
Publication
28111070 | J:239513
First Author: Spitzer MH
Year: 2017
Journal: Cell
Title: Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Volume: 168
Issue: 3
Pages: 487-502.e15
•
•
•
•
•
Publication
38640236 | J:348259
First Author: Niu L
Year: 2024
Journal: Sci Adv
Title: Noncovalently particle-anchored cytokines with prolonged tumor retention safely elicit potent antitumor immunity.
Volume: 10
Issue: 16
Pages: eadk7695
•
•
•
•
•
Publication
26679841 | J:227690
First Author: Ferretti R
Year: 2016
Journal: Genes Dev
Title: BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
Volume: 30
Issue: 1
Pages: 18-33
•
•
•
•
•
Publication
28851815 | J:249476
First Author: Rodríguez CI
Year: 2017
Journal: Mol Cancer Res
Title: EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.
Volume: 15
Issue: 12
Pages: 1792-1802
•
•
•
•
•
Publication
36672468 | J:332804
 
First Author: Mikheil D
Year: 2023
Journal: Cancers (Basel)
Title: Notch Signaling Suppresses Melanoma Tumor Development in BRAF/Pten Mice.
Volume: 15
Issue: 2
•
•
•
•
•
Publication
35385746 | J:328646
First Author: Jahid S
Year: 2022
Journal: Cell Rep
Title: Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer.
Volume: 39
Issue: 1
Pages: 110641
•
•
•
•
•
Publication
30664687 | J:295160
First Author: Bagati A
Year: 2019
Journal: Oncogene
Title: KLF9-dependent ROS regulate melanoma progression in stage-specific manner.
Volume: 38
Issue: 19
Pages: 3585-3597
•
•
•
•
•
Publication
29643229 | J:352709
 
First Author: Neubert NJ
Year: 2018
Journal: Sci Transl Med
Title: T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.
Volume: 10
Issue: 436
•
•
•
•
•
Publication
23563312 | J:201460
First Author: Hanna SC
Year: 2013
Journal: J Clin Invest
Title: HIF1α and HIF2α independently activate SRC to promote melanoma metastases.
Volume: 123
Issue: 5
Pages: 2078-93
•
•
•
•
•
Publication
35561684 | J:325979
First Author: Choi YS
Year: 2022
Journal: Cell
Title: Topical therapy for regression and melanoma prevention of congenital giant nevi.
Volume: 185
Issue: 12
Pages: 2071-2085.e12
•
•
•
•
•
Strain
MGI:5752238 | B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras<tm1.1Nesh> Cdkn2a<tm2.1Nesh> Stk11<tm1.1Rdp>
Attribute String: transgenic, targeted mutation, mutant strain, congenic
•
•
•
•
•
Publication
24003131 | J:201160
First Author: Ni TK
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
Volume: 110
Issue: 38
Pages: E3640-9
•
•
•
•
•
Publication
35768444 | J:326521
First Author: Vittoria MA
Year: 2022
Journal: Nat Commun
Title: Inactivation of the Hippo tumor suppressor pathway promotes melanoma.
Volume: 13
Issue: 1
Pages: 3732
•
•
•
•
•
Publication
24200692 | J:207627
First Author: Marsh Durban V
Year: 2013
Journal: J Clin Invest
Title: Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
Volume: 123
Issue: 12
Pages: 5104-18
•
•
•
•
•
Publication
36368445 | J:332391
     
First Author: Dong B
Year: 2022
Journal: J Invest Dermatol
Title: FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial‒Mesenchymal Transition.
•
•
•
•
•
Publication
29180473 | J:256302
First Author: Brighton HE
Year: 2018
Journal: Cancer Res
Title: New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.
Volume: 78
Issue: 2
Pages: 542-557
•
•
•
•
•
Publication
25472943 | J:221978
First Author: Deuker MM
Year: 2015
Journal: Cancer Discov
Title: PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.
Volume: 5
Issue: 2
Pages: 143-53
•
•
•
•
•
Publication
24736544 | J:212454
First Author: Ho PC
Year: 2014
Journal: Cancer Res
Title: Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.
Volume: 74
Issue: 12
Pages: 3205-17
•
•
•
•
•
Publication
38743908 | J:349161
     
First Author: Nozawa A
Year: 2024
Journal: Hum Mol Genet
Title: Lymphatic endothelial cell-specific NRAS p.Q61R mutant embryos show abnormal lymphatic vessel morphogenesis.
•
•
•
•
•
Publication
31679174 | J:282623
     
First Author: Aktary Z
Year: 2019
Journal: Pigment Cell Melanoma Res
Title: Sequencing two Tyr::CreERT2 transgenic mouse lines.
•
•
•
•
•
Publication
29855541 | J:280263
First Author: Vial J
Year: 2019
Journal: Cell Death Differ
Title: The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death.
Volume: 26
Issue: 3
Pages: 443-454
•
•
•
•
•
Publication
26923591 | J:234363
First Author: Micevic G
Year: 2016
Journal: Cell Rep
Title: DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.
Volume: 14
Issue: 9
Pages: 2180-2192
•
•
•
•
•
Publication
27236105 | J:235072
First Author: Halaban R
Year: 2016
Journal: J Invest Dermatol
Title: RASopathy Gene Mutations in Melanoma.
Volume: 136
Issue: 9
Pages: 1755-9
•
•
•
•
•
Publication
35422482 | J:324042
First Author: Martens S
Year: 2022
Journal: Cell Death Dis
Title: MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice.
Volume: 13
Issue: 4
Pages: 347
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Tg(tetO-BRAF*V600E)29Lc/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129/Sv * C57BL/6J * FVB * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras Stk11/Stk11 Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a Stk11
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ctnnb1/Ctnnb1 Tg(KRT14-rtTA)F42Efu/? Tg(tetO-EDN1,-lacZ)9Mhus/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: C57BL/6J * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Mc1r/Mc1r Tg(KRT14-rtTA)F42Efu/? Tg(tetO-EDN1,-lacZ)9Mhus/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Ezh2/Ezh2<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ezh2/Ezh2<+> Nras/Nras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor Tg(Tyr-cre/ERT2)13Bos/?
Background: STOCK Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor/Gt(ROSA)26Sor/Cvrk
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Publication
23123854 | J:189208
First Author: Mitra D
Year: 2012
Journal: Nature
Title: An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Volume: 491
Issue: 7424
Pages: 449-53
•
•
•
•
•
Publication
28202513 | J:242087
First Author: Steinberg SM
Year: 2017
Journal: Cancer Res
Title: Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.
Volume: 77
Issue: 7
Pages: 1599-1610
•
•
•
•
•
Publication
27977682 | J:238714
First Author: Pytel D
Year: 2016
Journal: PLoS Genet
Title: PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.
Volume: 12
Issue: 12
Pages: e1006518
•
•
•
•
•
Publication
28011934 | J:252348
First Author: Dominguez D
Year: 2017
Journal: J Immunol
Title: Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.
Volume: 198
Issue: 3
Pages: 1365-1375
•
•
•
•
•
Publication
30664764 | J:282386
First Author: Cheng WC
Year: 2019
Journal: Nat Immunol
Title: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.
Volume: 20
Issue: 2
Pages: 206-217
•
•
•
•
•
Publication
25252692 | J:220627
First Author: Burd CE
Year: 2014
Journal: Cancer Discov
Title: Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
Volume: 4
Issue: 12
Pages: 1418-29
•
•
•
•
•
Publication
20697345 | J:164588
First Author: Monahan KB
Year: 2010
Journal: Oncogene
Title: Somatic p16(INK4a) loss accelerates melanomagenesis.
Volume: 29
Issue: 43
Pages: 5809-17
•
•
•
•
•
Publication
27135738 | J:239472
First Author: Souroullas GP
Year: 2016
Journal: Nat Med
Title: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Volume: 22
Issue: 6
Pages: 632-40
•
•
•
•
•
Publication
19282848 | J:151023
First Author: Dankort D
Year: 2009
Journal: Nat Genet
Title: Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.
Volume: 41
Issue: 5
Pages: 544-52
•
•
•
•
•
Publication
33086062 | J:306533
First Author: Maitituoheti M
Year: 2020
Journal: Cell Rep
Title: Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Volume: 33
Issue: 3
Pages: 108293
•
•
•
•
•
Publication
22172720 | J:178598
First Author: Damsky WE
Year: 2011
Journal: Cancer Cell
Title: β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
Volume: 20
Issue: 6
Pages: 741-54
•
•
•
•
•
Publication
33184221 | J:329418
First Author: Infarinato NR
Year: 2020
Journal: Genes Dev
Title: BMP signaling: at the gate between activated melanocyte stem cells and differentiation.
Volume: 34
Issue: 23-24
Pages: 1713-1734
•
•
•
•
•
Publication
33951424 | J:306664
First Author: DeVito NC
Year: 2021
Journal: Cell Rep
Title: Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.
Volume: 35
Issue: 5
Pages: 109071
•
•
•
•
•
Publication
25673642 | J:224242
First Author: Xie X
Year: 2015
Journal: Cancer Discov
Title: Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.
Volume: 5
Issue: 4
Pages: 410-23
•
•
•
•
•
Publication
37335131 | J:340270
First Author: Adaku N
Year: 2023
Journal: Cancer Res
Title: Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis.
Volume: 83
Issue: 18
Pages: 3013-3025
•
•
•
•
•
Publication
27775706 | J:240803
First Author: Moynihan KD
Year: 2016
Journal: Nat Med
Title: Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses.
Volume: 22
Issue: 12
Pages: 1402-1410
•
•
•
•
•
Publication
29339718 | J:257726
First Author: Parfejevs V
Year: 2018
Journal: Nat Commun
Title: Injury-activated glial cells promote wound healing of the adult skin in mice.
Volume: 9
Issue: 1
Pages: 236
•
•
•
•
•
Publication
28753606 | J:244004
First Author: Ruiz R
Year: 2017
Journal: PLoS Genet
Title: The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.
Volume: 13
Issue: 7
Pages: e1006913
•
•
•
•
•
Publication
35267510 | J:327289
 
First Author: Vázquez-Naharro A
Year: 2022
Journal: Cancers (Basel)
Title: Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival.
Volume: 14
Issue: 5
•
•
•
•
•
Publication
31471106 | J:282377
First Author: Rivadeneira DB
Year: 2019
Journal: Immunity
Title: Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance.
Volume: 51
Issue: 3
Pages: 548-560.e4
•
•
•
•
•
Publication
27400148 | J:259419
First Author: Riedel A
Year: 2016
Journal: Nat Immunol
Title: Tumor-induced stromal reprogramming drives lymph node transformation.
Volume: 17
Issue: 9
Pages: 1118-27
•
•
•
•
•
Publication
29993000 | J:265039
First Author: Tokuo H
Year: 2018
Journal: Sci Rep
Title: Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis.
Volume: 8
Issue: 1
Pages: 10449
•
•
•
•
•
Publication
34348144 | J:311103
First Author: Eshiba S
Year: 2021
Journal: Cell Rep
Title: Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi.
Volume: 36
Issue: 5
Pages: 109492
•
•
•
•
•
Publication
22039523 | J:179725
First Author: Landrette SF
Year: 2011
Journal: PLoS One
Title: piggyBac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice.
Volume: 6
Issue: 10
Pages: e26650
•
•
•
•
•
Publication
37270599 | J:354056
First Author: Yang J
Year: 2023
Journal: Mol Cancer
Title: CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth.
Volume: 22
Issue: 1
Pages: 92
•
•
•
•
•
Publication
32686704 | J:298942
First Author: Tagliatela AC
Year: 2020
Journal: Sci Rep
Title: Coronin 1C inhibits melanoma metastasis through regulation of MT1-MMP-containing extracellular vesicle secretion.
Volume: 10
Issue: 1
Pages: 11958
•
•
•
•
•
Publication
35672316 | J:325350
First Author: Murphy BM
Year: 2022
Journal: Nat Commun
Title: Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation.
Volume: 13
Issue: 1
Pages: 3153
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom